Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Sildenafil and diastolic dysfunction after acute myocardial infarction trial: rationale and design.

Andersen MJ, Gustafsson F, Hassager C, Køber L, Møller JE.

Clin Cardiol. 2013 Apr;36(4):179-83. doi: 10.1002/clc.22103. Epub 2013 Feb 28.

2.

Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial.

Andersen MJ, Ersbøll M, Axelsson A, Gustafsson F, Hassager C, Køber L, Borlaug BA, Boesgaard S, Skovgaard LT, Møller JE.

Circulation. 2013 Mar 19;127(11):1200-8. doi: 10.1161/CIRCULATIONAHA.112.000056. Epub 2013 Feb 13.

4.

Sildenafil enhances systolic adaptation, but does not prevent diastolic dysfunction, in the pressure-loaded right ventricle.

Borgdorff MA, Bartelds B, Dickinson MG, Boersma B, Weij M, Zandvoort A, Silljé HH, Steendijk P, de Vroomen M, Berger RM.

Eur J Heart Fail. 2012 Sep;14(9):1067-74. doi: 10.1093/eurjhf/hfs094. Epub 2012 Jun 22.

5.

Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction.

Andersen MJ, Ersbøll M, Bro-Jeppesen J, Gustafsson F, Hassager C, Køber L, Borlaug BA, Boesgaard S, Kjærgaard J, Møller JE.

Circ Heart Fail. 2012 Jul 1;5(4):444-51. doi: 10.1161/CIRCHEARTFAILURE.112.967919. Epub 2012 Jun 15.

6.

Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.

Guazzi M, Vicenzi M, Arena R, Guazzi MD.

Circulation. 2011 Jul 12;124(2):164-74. doi: 10.1161/CIRCULATIONAHA.110.983866. Epub 2011 Jun 27.

8.

Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography.

Andersen MJ, Ersbøll M, Gustafsson F, Axelsson A, Hassager C, Køber L, Boesgaard S, Pellikka PA, Møller JE.

Int J Cardiol. 2013 Oct 3;168(3):2803-10. doi: 10.1016/j.ijcard.2013.03.122. Epub 2013 Apr 28.

PMID:
23628301
9.

Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.

Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, Felker GM, Goldsmith SR, Bart BA, McNulty SE, Ibarra JC, Lin G, Oh JK, Patel MR, Kim RJ, Tracy RP, Velazquez EJ, Anstrom KJ, Hernandez AF, Mascette AM, Braunwald E; RELAX Trial.

JAMA. 2013 Mar 27;309(12):1268-77. doi: 10.1001/jama.2013.2024.

10.

Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.

Behling A, Rohde LE, Colombo FC, Goldraich LA, Stein R, Clausell N.

J Card Fail. 2008 Apr;14(3):189-97. doi: 10.1016/j.cardfail.2007.11.006.

PMID:
18381181
11.

Sildenafil improves exercise hemodynamics in Fontan patients.

Van De Bruaene A, La Gerche A, Claessen G, De Meester P, Devroe S, Gillijns H, Bogaert J, Claus P, Heidbuchel H, Gewillig M, Budts W.

Circ Cardiovasc Imaging. 2014 Mar;7(2):265-73. doi: 10.1161/CIRCIMAGING.113.001243. Epub 2014 Jan 29.

12.

Relation between exercise capacity and left ventricular systolic versus diastolic function during exercise in patients after myocardial infarction.

Miyashita T, Okano Y, Takaki H, Satoh T, Kobayashi Y, Goto Y.

Coron Artery Dis. 2001 May;12(3):217-25.

PMID:
11352078
13.

Influence of exercise training on left ventricular diastolic function and its relationship to exercise capacity in patients after myocardial infarction.

Korzeniowska-Kubacka I, Bilińska M, Michalak E, Kuśmierczyk-Droszcz B, Dobraszkiewicz-Wasilewska B, Piotrowicz R.

Cardiol J. 2010;17(2):136-42.

PMID:
20544611
14.
15.

Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.

Lewis GD, Shah R, Shahzad K, Camuso JM, Pappagianopoulos PP, Hung J, Tawakol A, Gerszten RE, Systrom DM, Bloch KD, Semigran MJ.

Circulation. 2007 Oct 2;116(14):1555-62. Epub 2007 Sep 4.

16.

Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise.

Burgess MI, Jenkins C, Sharman JE, Marwick TH.

J Am Coll Cardiol. 2006 May 2;47(9):1891-900. Epub 2006 Apr 3.

17.

Importance of left ventricular diastolic function on maintenance of exercise capacity in patients with systolic dysfunction after anterior myocardial infarction.

Sumimoto T, Jikuhara T, Hattori T, Yuasa F, Kaida M, Hikosaka M, Takehana K, Tamura T, Sugiura T, Iwasaka T.

Am Heart J. 1997 Jan;133(1):87-93.

PMID:
9006295
18.

Effects of sildenafil on cardiopulmonary responses during stress.

Stanopoulos I, Hatzichristou D, Tryfon S, Tzortzis V, Apostolidis A, Argyropoulou P.

J Urol. 2003 Apr;169(4):1417-21.

PMID:
12629375
19.

Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.

Borlaug BA, Melenovsky V, Marhin T, Fitzgerald P, Kass DA.

Circulation. 2005 Oct 25;112(17):2642-9.

20.

Supplemental Content

Support Center